BAY-6096

N/A

Report date: 2023/03/22 16:47:50
NME

Base Information

Drug NameBAY-6096
Drug Alias NameBAY-6096
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-2b adrenergic receptor antagonists
TargetsAlpha-2b adrenergic receptor
Therapy Area/IndicationsMyocardial Reperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsMyocardial Reperfusion Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A